geranylgeraniol has been researched along with Glioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andres, DA; Crick, DC; Waechter, CJ | 1 |
| Andres, DA; Crick, DC; Danesi, R; Macchia, M; Waechter, CJ | 1 |
| Miyagi, K; Sun, LK; Yoshii, Y | 1 |
3 other study(ies) available for geranylgeraniol and Glioma
| Article | Year |
|---|---|
Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells.
Topics: Animals; Cell Line; Chlorocebus aethiops; Cholesterol; Cysteine; Diterpenes; Electrophoresis, Polyacrylamide Gel; Farnesol; Glioma; Kinetics; Mevalonic Acid; Neoplasm Proteins; Protein Biosynthesis; Protein Prenylation; Proteins; Rats; Tritium; Tumor Cells, Cultured; Ubiquinone | 1995 |
Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells.
Topics: Animals; Cell Division; Diterpenes; Electrophoresis, Polyacrylamide Gel; Farnesol; Glioma; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mevalonic Acid; Molecular Weight; Nerve Tissue Proteins; Polyisoprenyl Phosphates; Protein Prenylation; Rats; Thymidine; Tumor Cells, Cultured | 1998 |
Cytotoxic effect through fas/APO-1 expression due to vitamin K in human glioma cells.
Topics: Antifibrinolytic Agents; Apoptosis; Catalase; Cell Division; Cytotoxins; Diterpenes; DNA Fragmentation; fas Receptor; Glioma; Glutathione; Hemostatics; Humans; Peroxides; Reactive Oxygen Species; Tumor Cells, Cultured; Vitamin K; Vitamin K 1; Vitamin K 2 | 2000 |